183 related articles for article (PubMed ID: 31801787)
1. Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T; ;
Diabetes Care; 2020 Feb; 43(2):314-320. PubMed ID: 31801787
[TBL] [Abstract][Full Text] [Related]
2. Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
Okada S; Morimoto T; Ogawa H; Sakuma M; Matsumoto C; Soejima H; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y;
Diabetes Care; 2018 Aug; 41(8):1757-1764. PubMed ID: 29909377
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
[TBL] [Abstract][Full Text] [Related]
4. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
Okada S; Morimoto T; Ogawa H; Kanauchi M; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sakuma M; Saito Y;
Diabetes Care; 2011 Jun; 34(6):1277-83. PubMed ID: 21515838
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.
Saito Y; Morimoto T; Ogawa H; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sugiyama S; Okada S; Akai Y;
Diabetes Care; 2011 Feb; 34(2):280-5. PubMed ID: 21270185
[TBL] [Abstract][Full Text] [Related]
7. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
[TBL] [Abstract][Full Text] [Related]
8. Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.
Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Jinnouchi H; Waki M; Akai Y; Ishii H; Saito Y;
PLoS One; 2016; 11(1):e0147635. PubMed ID: 26808136
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
10. Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: subanalysis from the JPAD trial.
Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Sakuma M; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
J Cardiol; 2013 Sep; 62(3):165-70. PubMed ID: 23778008
[TBL] [Abstract][Full Text] [Related]
11. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Uemura S; Kanauchi M; Doi N; Sakuma M; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
Circ J; 2012; 76(6):1526-32. PubMed ID: 22447019
[TBL] [Abstract][Full Text] [Related]
12. Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes.
Okada S; Morimoto T; Ogawa H; Soejima H; Matsumoto C; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y
J Gen Intern Med; 2021 Mar; 36(3):632-639. PubMed ID: 33063203
[TBL] [Abstract][Full Text] [Related]
13. Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness.
Hong S; Nam M; Little BB; Paik S; Lee K; Woo J; Kim D; Kang J; Chun M; Park Y
Heart Vessels; 2019 Nov; 34(11):1758-1768. PubMed ID: 31056733
[TBL] [Abstract][Full Text] [Related]
14. Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus.
Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T
BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35361621
[TBL] [Abstract][Full Text] [Related]
15. Dose-Dependent Effect of Aspirin Use in Reducing Diabetes-Associated Dementia Risk Among Elderly Patients With Type 2 Diabetes Mellitus.
Sun M; Chen WM; Wu SY; Zhang J
J Am Med Dir Assoc; 2024 May; 25(5):889-897.e2. PubMed ID: 38642589
[TBL] [Abstract][Full Text] [Related]
16. Does aspirin use reduce cardiovascular risk in diabetes?
Colwell JA
Nat Rev Endocrinol; 2009 Apr; 5(4):188-90. PubMed ID: 19352314
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
Pradhan AD; Cook NR; Manson JE; Ridker PM; Buring JE
Diabetes Care; 2009 Jan; 32(1):3-8. PubMed ID: 18835953
[TBL] [Abstract][Full Text] [Related]
18. [Series, clinical study from Japan and its reflections; Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial].
Ogawa H
Nihon Naika Gakkai Zasshi; 2011 Jan; 100(1):218-23. PubMed ID: 21387659
[No Abstract] [Full Text] [Related]
19. The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.
Solomon DH; Libby P; Yeomans ND; Wang Q; Wolski KE; Nissen SE; Husni ME
Rheumatology (Oxford); 2018 Aug; 57(8):1364-1369. PubMed ID: 29688503
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients at high risk.
Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Sugiyama S; Jinnouchi H; Waki M; Doi N; Horii M; Kawata H; Somekawa S; Soeda T; Uemura S; Saito Y;
Circ J; 2013; 77(12):3023-8. PubMed ID: 24042256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
